Mason Street Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-20,111
| Closed | -$80K | – | 1544 |
|
|
2019
Q4 | $80K | Buy |
20,111
+542
| +3% | +$2.16K | ﹤0.01% | 1498 |
|
|
2019
Q3 | $96K | Buy |
19,569
+615
| +3% | +$3.02K | ﹤0.01% | 1477 |
|
|
2019
Q2 | $115K | Buy |
18,954
+776
| +4% | +$4.71K | ﹤0.01% | 1451 |
|
|
2019
Q1 | $106K | Buy |
18,178
+600
| +3% | +$3.5K | ﹤0.01% | 1513 |
|
|
2018
Q4 | $237K | Buy |
17,578
+822
| +5% | +$11.1K | 0.01% | 1270 |
|
|
2018
Q3 | $325K | Buy |
16,756
+2,841
| +20% | +$55.1K | 0.01% | 1237 |
|
|
2018
Q2 | $356K | Buy |
13,915
+559
| +4% | +$14.3K | 0.01% | 1201 |
|
|
2018
Q1 | $269K | Buy |
13,356
+817
| +7% | +$16.5K | 0.01% | 1251 |
|
|
2017
Q4 | $252K | Buy |
12,539
+430
| +4% | +$8.64K | 0.01% | 1267 |
|
|
2017
Q3 | $251K | Buy |
12,109
+1,338
| +12% | +$27.7K | 0.01% | 1255 |
|
|
2017
Q2 | $159K | Buy |
10,771
+623
| +6% | +$9.2K | ﹤0.01% | 1355 |
|
|
2017
Q1 | $162K | Buy |
10,148
+783
| +8% | +$12.5K | ﹤0.01% | 1334 |
|
|
2016
Q4 | $118K | Buy |
9,365
+483
| +5% | +$6.09K | ﹤0.01% | 1394 |
|
|
2016
Q3 | $249K | Buy |
8,882
+1,788
| +25% | +$50.1K | 0.01% | 1133 |
|
|
2016
Q2 | $248K | Buy |
7,094
+736
| +12% | +$25.7K | 0.01% | 1102 |
|
|
2016
Q1 | $174K | Buy |
+6,358
| New | +$174K | 0.01% | 1182 |
|
|
2015
Q1 | – | Sell |
-41,900
| Closed | -$1.15M | – | 1803 |
|
|
2014
Q4 | $1.15M | Buy |
+41,900
| New | +$1.15M | 0.01% | 1147 |
|